| __timestamp | Gilead Sciences, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2854000000 | 1488000000 |
| Thursday, January 1, 2015 | 3014000000 | 1525000000 |
| Friday, January 1, 2016 | 5098000000 | 2111000000 |
| Sunday, January 1, 2017 | 3734000000 | 1848000000 |
| Monday, January 1, 2018 | 5018000000 | 1213000000 |
| Tuesday, January 1, 2019 | 9106000000 | 1010000000 |
| Wednesday, January 1, 2020 | 5039000000 | 997000000 |
| Friday, January 1, 2021 | 5363000000 | 967000000 |
| Saturday, January 1, 2022 | 4977000000 | 838000000 |
| Sunday, January 1, 2023 | 6923000000 | 953000000 |
| Monday, January 1, 2024 | 5907000000 | 998000000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Gilead Sciences, Inc. and Teva Pharmaceutical Industries Limited have showcased contrasting strategies in their R&D investments. From 2014 to 2023, Gilead consistently outpaced Teva, with its R&D expenses peaking at nearly 9 billion in 2019, a staggering 300% more than Teva's highest expenditure in the same period. This trend highlights Gilead's aggressive pursuit of new therapies and treatments. Meanwhile, Teva's R&D spending remained relatively stable, reflecting a more conservative approach. As the pharmaceutical landscape evolves, these spending patterns may influence each company's ability to innovate and capture market share. The data underscores the importance of strategic investment in R&D for long-term success in the pharmaceutical industry.
AbbVie Inc. or Gilead Sciences, Inc.: Who Invests More in Innovation?
R&D Insights: How Gilead Sciences, Inc. and Axsome Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Gilead Sciences, Inc. vs Perrigo Company plc
Comparing Innovation Spending: Gilead Sciences, Inc. and Novavax, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and Neurocrine Biosciences, Inc. Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Axsome Therapeutics, Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated
R&D Insights: How Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. Allocate Funds
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs MannKind Corporation: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs Novavax, Inc.: Strategic Focus on R&D Spending